Opiant Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose Read more
REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases Read more
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay Read more
Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu in Flu Care Read more
FDA Approves Pfizer’s Biosimilar, RUXIENCE (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions Read more
Merck and Eisai Receive Third Breakthrough Therapy Designation from FDA for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination Treatment Read more
Johnson & Johnson Establishes International Consortium to Advance Pioneering Science in the Fight to End Tuberculosis Read more
ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA” Read more
Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines Read more